key: cord-0838508-oltbv84g
authors: Wee, Liang E.; Tan, Jing Y.; Chung, Shimin J.; Conceicao, Edwin P.; Hock Tan, Ban; Venkatachalam, Indumathi
title: Zero health‐care‐associated respiratory viral infections among solid organ transplant recipients: Infection prevention outcomes during COVID‐19 pandemic
date: 2021-02-17
journal: Am J Transplant
DOI: 10.1111/ajt.16499
sha: b5713dc582a9aadf65feacce05b83d45e6823b15
doc_id: 838508
cord_uid: oltbv84g

We read with interest the paper by Coll et al. that reported a mortality rate of 27% in a large series of transplant recipients with concurrent COVID-19; with nosocomial acquisition in 13% of cases.1 Outside the pandemic setting, however, solid-organ-transplant (SOT) recipients are more likely to experience prolonged and severe illness from common respiratory-viral-infections (RVIs), and healthcare-associated-RVI (HA-RVI) is a significant issue. The impetus for implementation of aggressive infection-prevention measures against COVID-19 on transplant units may reduce HA-RVI as a positive consequence.

To the Editor:

We read with interest the paper by Coll 

COVID-19 in transplant recipients: the Spanish experience

Respiratory viruses in transplant recipients: more than just a cold. Clinical syndromes and infection prevention principles

Respiratory surveillance wards as a strategy to reduce nosocomial transmission of COVID-19 through early detection: the experience of a tertiary-care hospital in Singapore

Public health measures during COVID-19 pandemic reduced hospital admissions for community respiratory viral infections

Practical considerations for solid organ transplantation during the COVID-19 global outbreak: the experience from Singapore